Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00187343 | A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT) | completed | Phase 3 | 340 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 8, 2008 | clinicaltrials |
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00025688 | Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer | unknown | Phase 3 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00150917 | RCT of a Group Intervention for Women With a Family History of Breast Cancer | completed | Phase 3 | 150 | University Health Network, TorontoOTHER | 1 | Jun 17, 2008 | clinicaltrials |
| NCT00201435 | Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC | completed | Phase 2 / Phase 3 | 224 | Norwegian Breast Cancer GroupOTHER | 1 | May 20, 2008 | clinicaltrials |
| NCT00117910 | Treatment for Elderly Patients With High Risk Breast Cancer | completed | Phase 3 | — | AmgenINDUSTRY | 0 | May 16, 2008 | clinicaltrials |
| NCT00430001 | Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer | unknown | Phase 3 | 300 | Danish Breast Cancer Cooperative GroupOTHER | 1 | May 9, 2008 | clinicaltrials |
| NCT00001338 | A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer | completed | Phase 3 | 65 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | completed | Phase 3 | 478 | Hellenic Oncology Research GroupOTHER | 1 | Jan 21, 2008 | clinicaltrials |
| NCT00582244 | Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial(EVA project) | unknown | Phase 3 | 325 | The Netherlands Cancer InstituteOTHER | 0 | Dec 28, 2007 | clinicaltrials |
| NCT00201942 | PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | completed | Phase 3 | 336 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 18, 2007 | clinicaltrials |
| NCT00267553 | Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer | terminated | Phase 3 | 200 | Intarcia TherapeuticsINDUSTRY | 4 | Sep 10, 2007 | clinicaltrials |
| NCT00525642 | Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer | unknown | Phase 2 / Phase 3 | 603 | Fudan UniversityOTHER | 1 | Sep 6, 2007 | clinicaltrials |
| NCT00097344 | The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer | terminated | Phase 3 | 842 | Intarcia TherapeuticsINDUSTRY | 5 | Aug 23, 2007 | clinicaltrials |
| NCT00294151 | Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer | unknown | Phase 3 | 30 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jul 13, 2007 | clinicaltrials |
| NCT00201929 | A Decision Aid for Women With Early Stage Breast Cancer | completed | Phase 3 | 300 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00207324 | The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions | completed | Phase 3 | 100 | British Columbia Cancer AgencyOTHER | 1 | Jun 27, 2007 | clinicaltrials |
| NCT00191438 | Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents | completed | Phase 3 | 300 | Eli Lilly and CompanyINDUSTRY | 6 | May 28, 2007 | clinicaltrials |
| NCT00114816 | Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer | completed | Phase 3 | 1,500 | Finnish Breast Cancer GroupOTHER | 1 | May 21, 2007 | clinicaltrials |
| NCT00099281 | DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer | terminated | Phase 3 | 700 | YM BioSciencesINDUSTRY | 1 | Feb 28, 2007 | clinicaltrials |
| NCT00190593 | Raloxifene Use for The Heart | completed | Phase 3 | 10,000 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00161980 | Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites | completed | Phase 3 | — | Baxter Healthcare CorporationINDUSTRY | 4 | Oct 23, 2006 | clinicaltrials |
| NCT00359060 | Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE Study | completed | Phase 3 | 180 | UMC UtrechtOTHER | 1 | Oct 13, 2006 | clinicaltrials |
| NCT00034125 | Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 5 | Jul 19, 2006 | clinicaltrials |
| NCT00046527 | Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | completed | Phase 3 | 460 | Celgene CorporationINDUSTRY | 1 | Jul 13, 2006 | clinicaltrials |
| NCT00289263 | Maintenance Chemotherapy in Metastatic Breast Cancer | unknown | Phase 3 | 524 | MANTA 1 Study Italian Collaborative GroupOTHER | 1 | Feb 9, 2006 | clinicaltrials |
| NCT00138814 | Boost Use in Breast Conservation Radiotherapy | unknown | Phase 3 | 680 | St George Hospital, AustraliaOTHER | 1 | Dec 15, 2005 | clinicaltrials |
| NCT00189631 | UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 1 | Dec 8, 2005 | clinicaltrials |
| NCT00189644 | 6 FEC 100 Vs 4 FEC 100 Followed by 4 Taxol in N+ Breast Cancer | unknown | Phase 3 | — | Association Européenne de Recherche en OncologieOTHER | 0 | Sep 19, 2005 | clinicaltrials |
| NCT00148057 | Diet and Breast Cancer Prevention Trial | completed | Phase 3 | 4,695 | University Health Network, TorontoOTHER | 1 | Sep 7, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Sep 8, 2008source: clinicaltrials